Do 5-Alpha Reductase Inhibitors Influence the Features of Suspicious Lesions on Magnetic Resonance Imaging and Targeted Biopsy Results for Prostate Cancer Diagnosis?
5-ARI treatment is not associated with PIRADS score alterations or targeted biopsy results. Patients treated by 5-ARIs with suspicious lesions should not be addressed differently during the mpMRI-related diagnostic process.
Authors
- Tomer Mendelson (ORCID: https://orcid.org/0009-0001-8873-4724)
- Snir Dekalo (ORCID: https://orcid.org/0000-0001-8031-9684)
- Karin Lifshitz (ORCID: https://orcid.org/0000-0002-5668-1330)
- Yuval Bar‐Yosef (ORCID: https://orcid.org/0000-0003-3769-6606)
- Ofer Yossepowitch (ORCID: https://orcid.org/0009-0005-5507-6541)
- Ziv Savin (ORCID: https://orcid.org/0000-0002-5012-7312)
- Roy Mano (ORCID: https://orcid.org/0000-0003-3855-0211)
- Gal Keren‐Paz
- Rina Neeman (ORCID: https://orcid.org/0009-0002-0844-9382)
- Avishay Shem-Tov Dlugy (ORCID: https://orcid.org/0009-0006-8144-0674)
- Miri Grinbaum
Institutions
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
Publication Details
- Journal
- Diagnostics
- Published
- 2024-11-15
- DOI
- https://doi.org/10.3390/diagnostics14222567
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42